Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery

• Status: Completed
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparing 2 different anaesthetic methods during abdominal aortic aneurysm surgery. The patients will be followed up 30 days postoperative. Number of patients included will be 200. Perioperative details will be analyzed.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sykehuset i Vestfold HF
• Collaborator: Oslo University Hospital
• Treatments: Anesthetics; Propofol; Remifentanil; Sevoflurane

Criteria

Inclusion Criteria:

• Patients who are planned for open, elective abdominal aortic aneurysm surgery.

• ASA group 1-4.

Exclusion Criteria:

• Patients below 18 years.

• Patients who are included in other pharmaceutical studies.

• Opioids-, benzodiazepins-, antiepileptic drugs-, alcohol- and α2-agonists abuse.

• Pregnant and breastfeeding women.

• Patients with familiar history of malignant hyperthermia.

• Patients with known hypersensitivity for opioids, propofol or volative anaesthetics.

• Patients with considerable arrythmia (atrial fibrillation /atrial flutter is acceptable). Uncontrolled hypertension, serious psychiatric disease.

• Patients with unstable angina pectoris or myocardial infarction last month before inclusion.

• Acute abdominal aortic surgery. Acute dissection or rupture.

• Planned laparoscopic abdominal aortic aneurysm surgery.